NOVAGALI PHARMA COMPLETES EUR26 MILLION FINANCING

A A

Novagali Pharma SA, a privately-held biopharmaceutical company that develops novel ophthalmic products announced today it has secured EUR26 million in a new financing round involving participation of new and existing investors. With this new funding, the total capital raised by Novagali since its inception equals EUR44 million. AGF Private Equity and Bernard Chauvin joined the group of Novagali Pharma's investors: 1.2.3. Multinova, Auriga Partners, CDC Entreprises Innovation, Credit Agricole Private Equity, Edmond de Rothschild Investment Partners, FCJE managed by CDC Entreprises - FP Gestion and Siparex Ventures.
PR Newswire UK